期刊文献+

α_2肾上腺素受体激动剂镇静镇痛作用的研究进展 被引量:15

Research Progress in Sedative and Analgesic Effects of Alpha-2 Adrenergic Receptor
下载PDF
导出
摘要 α2肾上腺素受体(α2-AR)激动剂可乐定,早在20世纪70年代初就已经作为强效的抗高血压药上市。其主要通过激动大脑和脊髓α2-AR产生镇静、镇痛效应,临床应用中具有减少术中麻醉药用量、增强术后镇静、镇痛及与其他镇痛药相互协同的特点。现就α2-AR结构、分型、分布和生理功能及其常用激动剂的临床应用情况和镇静镇痛作用机制的研究进展予以综述。 Back in early 1970s,clonidine,an alpha-2 adrenergic(α2-AR) receptor agonist,has been used as a listed potent anti-hypertensive.Alpha-2 adrenergic receptor produces sedative and analgesic effects mainly through the activation of brain and spinal cord alpha-2 adrenergic receptor.α2-AR receptor agonist is characteristic of reducing the dose of intraoperative anesthetic,increasing postoperative sedation and analgesia,and synergizing with other analgesics in clinical practice.This article reviews the structure,classification,distribution and physiological function and clinical application of α2-AR agonists,in addition to the research progress of sedative and analgesic mechanisms.
出处 《医学综述》 2011年第9期1386-1388,共3页 Medical Recapitulate
关键词 Α2肾上腺素受体激动剂 镇静 镇痛 Alpha-2adrenergic receptor agonist Sedation Analgesia
  • 相关文献

参考文献18

  • 1Madsen O,Willemsen D,Ursing BM,et al.Molecular evolution of the mammalian alpha 2B adrenergic receptor[J].Mol Biol Evol,2002,19(12):2150-2160.
  • 2Lawhead RG,Blaxall HS,Bylund DB.Alpha-2A is the predominant alpha-2adrenergic receptor subtype in human spinal cord[J].Anesthesiology,1992,77(5):983-991.
  • 3Bylund DB,Iversen LJ,Matulka WJ,et al.Characterization of alpha-2D adrenergic receptor subtypes in bovine ocular tissue homogenates[J].J Pharmacol Exp Ther,1997,281(3):1171-1177.
  • 4Stone LS,Broberger C,Vulchanova L,et al.Differential distribution of alpha 2A and alpha 2C adrenergic receptor immunoreactivity in the rat spinal cord[J].J Neurosci,1998,18(15):5928-5937.
  • 5Makaritsis KP,Johns C,Gavras I,et al.Role of alpha(2)-adrenergic receptor subtypes in the acute hypertensive response to hypertonic saline infusion in anephric mice[J].Hypertension,2000,35(2):609-613.
  • 6Paalzow L.Analgesia produced by clonidine in miceand rats[J].J Pharm Pharmacol,1974,26(5):361-363.
  • 7Szumita PM,Baroletti SA,Anger KE,et al.Sedation and analgesia in the intensive care unitevaluating the role of dexmedetomidine[J].Am J Health Syst Pharm,2007,64(1):37-44.
  • 8Venn RM,Hell J,Grounds RM.Pharmacokinetics of dexmedetomidine infusions for sedation of postoperative patients requiring intensive caret[J].Br J Anaesth,2002,88(5):669-675.
  • 9Lin TF,Yeh YC,Lin FS,et al.Effect of combining dexmedetomidine and morphine for intravenous patient-controlled analgesia[J].Br J Anaesth,2009,102(1):117-122.
  • 10Gunell E,Karabay Yavasoglu NU,Apaydin S,et al.Analysis of the antinociceptive effect of systemic administration of tramadol and dexmedetomidine combination on rat models of acute and neuropathic pain[J].Pharmacol Bioehem Behav,2007,88(1):9-17.

共引文献5

同被引文献167

引证文献15

二级引证文献137

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部